Fluorine-18-FDG PET and Iodine-123-IMT SPECT -in the evaluation of brain tumors

Journal of Nuclear Medicine

Volumn 38, Issue 5, 1997, Pages 802-808

  Weber, Wolfgang ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Fluorine 18 fdg; Gliomas; Iodine 123 imt

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METIROSINE; METIROSINE I 123; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN SCINTISCANNING; CANCER SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; GLIOBLASTOMA; GLUCOSE METABOLISM; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MALE; OLIGODENDROGLIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; DEOXYGLUCOSE; EVALUATION STUDIES; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; GLIOBLASTOMA; HUMANS; IODINE RADIOISOTOPES; MALE; METHYLTYROSINES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030979770     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Blasberg RG. Prediction of brain tumor therapy response by PET. J Neurooncol 1994;22:281-286.
2. Archibald YM, Lunn D, Lesley AR, et al. Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 1994;80:247-253.
3. Salcman M, Scholtz H, Kaplan RS, Kulik S. Long-term survival in patients with malignant astrocytoma. Neurosurgery 1994;34:213-219.
4. Sartor K. Tumors and related conditions. In: Sartor K, ed. MR imaging of the skull and brain: a correlative text-atlas, 1st ed. Berlin: Springer; 1992:249-493.
5. Di Chiro G, De La Paz RL, Brooks RA, et al. Glucose utilization of cerebral gliomas measured by 18F-fluorodeoxyglucose and positron emission tomography. Neurology 1982;32:1323-1329.
6. Di Chiro G. Positron emission tomography using [18F]fluorodeoxyglucose in brain tumors: a powerful and prognostic tool. Invest Radial 1986;22:360-371.
7. Alavi JB, Alavi A, Chawluk J, et al. Positron emission tomography in patients with glioma: a predictor of prognosis. Cancer 1988;62:1074-1078.
8. Glantz MJ, Huffman JM, Coleman RE, et al. Identification of early recurrence of -primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission -tomography. Ann Neural 1991;29:347-355.
9. Tyler JL, Diksic M, Villemure JG, et al. Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med 1987;28:1123-1133.
10. Janus TJ, Kirn EE, Tilbury R, Bruner JM, Yung WK. Use of [18F]fluorodeoxyglucose -positron emission tomography in patients with primary malignant brain tumors. Ann Neural 1993;33:540-548.
11. Kahn D, Follett KA, Bushnell DL, Nathan MA, et al. Diagnosis of recurrent brain -tumor: value of 201T1 SPECT versus '8F-fluordeoxyglucose PET. Am J Roegentrol 1994;163:1459-1465.
12. Hawkins RA, Huang SC, Barrio JR, et al. Estimation of local cerebral protein synthesis -rate with L-[l-' 'C]leucin and PET: methods, model and results in animals and humans. J Cereb Blood Flow Metab 1989;9:446-460.
13. Schober O. Meyer GJ, Duden C, et al. Die Aufnahme von Aminosäuren in Hirntumoren mit der Positronen-Emissionstomographie als Indikator für die Beurtei-lung von Stoffwechselaktivität und Malignität. Fortxchr Geh Rontgenst Nuklcarmcd 1487; 147:503-509.
14. Kloss G, Leven M. Aceumulation of radioiodinated tyrosine derivatives in adrenal medulla and in melanomas. Eur J Nue l Med 1979:4:179-186.
15. Langen KJ, Coenen HH, Roosen N, et al. SPECT studies of brain tumors wilh L-3-[123I]iodo-alpha-methyl tyrosine: comparison with PET. 124I-IMT and first clin-ical results. J Nucl Med 1990:31:281-286.
16. Kawai K, Fujibayashi Y, Saji H, et al. A strategy for the study of cerebral amino acid transport using iodine-123-labeled radiopharmaceutical: 3-iodo-alpha-mcthyI-L-ty-rosine../ Nucl Med 1991:32:819-824.
17. Langen KJ, Roosen N, Coenen HH, et al. Brain and brain tumor uptake of L-3[ml]iodo-alpha-methyl tyrosine: competition with natural L-amino-acids. J Nucl Med 1991;32:1225-1228.
18. Biersack HJ, Coenen HH, Stöcklin G, et al. Imaging of brain tumors with L-3-[l123]iodo-alpha-methyl tyrosine and SPECT. J Nucl Med 1989;30:110-112.
19. Harnacher K, Coenen HH, Stöcklin G. Efficient stereospecific synthesis of no-carrier-added 2-F-18-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235-238.
20. Krummeich C, Holschbach M, Stöcklin G. Direct n.c.a. electrophiiic radionation of tyrosine analogues: their in vivo stability and brain uptake in mice. Appl Radial Isot 1994:45:929-935.
21. Munzing W, Raithel E, Tatsch K, Hahn K. Entwurf eines speziellen Kollimators für J-123 und erste Erfahrungen bei der Anwendung [Abstract]. Nuklearmedizin 1996:35: A48.
22. Cohen J. A coefficient of agreement for nominal scales. Educ Psvchol Meas 1960;20:37-46.
23. Delbeke D, Meyerowitz CM, Lapdius RL, et al. Optimal cutoff levels of F-18-fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 1995;195:47-52.
24. Ishizu K, Nishizawa S, Yonekura Y, et al. Effects of hyperglycemia on FDG uptake in human brain and glioma. J Nucl Med 1994;35:1104-1109.
25. Ogawa T, Kanno I, Shishido F, et al. Clinical value of PET with F-18-fluordeoxyglu-cose and L-methyl-C-11-methionine for diagnosis of recurrent brain tumor and radiation injury. A eta Radial 1991;32:197-202.
26. Mosskin M, Ericson K, Hindmarsh T, et al. PET compared with MR1 and CT in supratentorial gliomas using multiple stereotactic biopsies as a reference. Ada Radiol 1989:30:225-232.
27. Tovi M, Lilja A, Bergstroem M, Ericsson A, Bergstroem K, Hartman M. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radial 1990:31:417429.
28. Ogawa T, Shishido F, Kanno I, et al. Cerebral glioma: evaluation with methionine -PET. Radiology 1993; 186:45-53.
29. Lemaire C. Production of L-F-18-fluoro amino acids for protein synthesis: overview and recent developments in nucleophilic syntheses. In: Mazoyer BM, Heiss WD, Comar D, eds. PET studies of amino acid metabolism and protein synthesis. Dordrecht: Kluwer Academic Publishers; 1993:89-108.
30. Isselbacher KJ. Increased uptake of amino acids and 2-deoxy-D-glucose by virus-transformed cells in culture. Proc Nat Acad Sei USA 1972;69:585-589.
31. Minn H, Clavo AC, Grenman R, Wahl RL. In vitro comparison of cell proliferation -kinetics and uptake of fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 1995;36:252-258.
32. Ericson K, Lilja A, Bergström M, et al. Positron emission tomography with C-11-L-methionine, C-l 1-D-glucose and Ga-68-EDTA in suprantentorial tumors. J Comput Assist Tomogr 1985;9:683-689.
33. Wienhard K, Herholz K, Coenen HH, et al. Increased amino acid transport into brain -tumors measured by PET of L-2-F-18-fluorotyrosine../M
34. Pruim J, Willemsen ATM, Molenaar, WM, et al. Brain tumors: L-l-C-11-tyrosine PET -for visualization and quantification of protein synthesis rate. Radiology 1995; 197:221226.
35. Earnest F, Kelly PJ, Scheithauer BW, et al. Cerebral astrocytomas: histopathological -correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 1988;166:823-827.
36. Kelly PJ, Daumas-Dupport C, Kispert DB, et al. Imaging-based stereotactic serial -biopsies in untreated intracranial glial neplasms. J Neurosurg 1987;66:865-874.
37. Karson UL, Leibel SA, Wallner K, Davis LW, Brady LW. Brain. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology, 2nd ed. Philadelphia: JB Lippincott; 1992:515-563.
38. Langen KJ, Csaplar K, Ziemons K, et al. Studies of amino acid uptake in gliomas with 123I-alpha-L-methyltyrosine: comparison with "C-L-methionine in vitro and in vivo -[Abstract]. J Cereb Blood Flow Metab 1995;15(suppl):S172.
39. Guth-Tougelidis B, Müller S, Mehdorn MM, et al. Anreicherung von DL-3-'23I-alpha-methyltyrosin in hirntumorrezidiven. Nuklearmedizin 1995:34:71-75.
40. Ogawa T, Hatazawa J, Atsushi I, et al. Carbon-11-methionine PET evaluation of -intracerebral hematoma: distinguishing neoplastic from non-neoplastic hematoma. J Nucl Med 1995:36:2175-2179.
41. Dethy S, Goldman S, Blecic S, et al. Carbon-11-methionine and 18fluorine-FDG-PET -study in brain hematoma. J Nucl Med 1994;35:1162-1166.
42. Wagner W, Schuller P, Willich N, et al. Intraoperative Strahlentherapie (1ORT) maligner Hirntumoren. Strahlenther Onkol 1995;17:154-164.
43. Pietrzyk U, Herholz K, Fink G, et al. An interactive technique for three-dimensional -image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med 1994;35:2011-2018.
44. Rehm K, Stromer SC, Anderson JR, Schaper KA, Rottenberg DA. Display of merged multimodality brain images using interleaved pixels with independent color scales. J Nucl Med 1994;35:1815-1821.